ISOkine® Premium · IK2000
IFN-gamma (human)
Recombinant IFN-gamma (human) for immune activation, antiviral. Animal-free and endotoxin-free, produced in barley with >95% purity and <0.01 EU/µg endotoxin, and batch-to-batch consistency you can validate once and scale.
Datasheets, SDS, and Certificate of Origin available for download or on request.
About IFN-gamma (human)
IFN-gamma, a type II interferon and an acid-labile interferon, is mainly produced by CD4 and CD8 T-lymphocytes and natural killer cells activated by antigens, mitogens or alloantigen’s. IFN-gamma shows no significant homology with IFN-beta or IFN-alpha. IFN-gamma has antiviral and antiparasitic activities and exhibits also immunoregulatory and proinflammatory activities. IFN-gamma induces cytokine production and promotes antigen presentation by up regulating the expression of MHC proteins as well as other antigen proteins. In contrast to other interferons, which are mostly antiviral, the main activity of IFN-gamma seems to be immunomodulatory. Human IFN-gamma is species-specific and is only biologically active in human and primate.
Biological activity
The bioactivity of ISOkine® recombinant human IFN-gamma is assayed by measuring its dose dependent effect in a cytotoxicity assay, in the presence of TNF-alpha, on HT-29 (human carcinoma) cells.
The ED50 for this effect is <0.4 ng/ml corresponding to specific activity of > 2.5 x 10e6 U/mg.
We recommend that the optimal concentration for each specific application be determined by an initial dose-response assay. Each batch of ISOkine® growth factor is tested for bioactivity and verified to have comparable activity to a commercial source.
IFN-gamma (human) bioactivity: dose-dependent response assay.
At a glance
Specifications
Starting price for research quantities. Volume pricing on request.
Purity verified by SDS-PAGE gel analysis on every lot.
Produced in an endotoxin-free barley host, tested per batch.
Datasheet specifications
| Property | Detail |
|---|---|
| Source | Produced in the endosperm tissue of barley grain (Hordeum vulgare). |
| Molecular Weight | Recombinant human IFN-gamma contains 143 amino acids and a 16 a.a. Histidine-based tag for a total length of159 a.a. and has a predicted molecular mass of 18.8 kDa. As of glycosylation, the recombinant protein migrates with an apparent molecular mass of 20-25 kDa in SDS-PAGE. |
| Purity | Greater than 95% by SDS-PAGE gel analysis. |
| Endotoxin Level | Endotoxin level is < 0.0100 EU per μg of ISOkine® product. |
| Pyrogen Free | Purified ISOkine® product carries no pyrogenic or pro-inflammatory contaminants, as assayed with monocyte activation test (MAT Assay) using Human 10-plex Cytokine Assay measuring IL-6, TNF-alpha and IL-1 beta induction. |
| Storage | The lyophilized protein, though stable at room temperature for few weeks, is best stored at -20°C. Reconstituted protein should be used immediately or stored in working aliquots at -20°C. Avoid repeated freeze-thaw cycles. |
| Stability | Highly stable as supplied for a maximum of 5 years and a minimum of 12 months from date of receipt (check expiration date specific for each lot# on Certificate of Analysis) |
| Reconstitution | Note: Always centrifuge the vial before opening. It is recommended to reconstitute the lyophilized protein in sterile buffered saline to a concentration of no less than 100 µg/ml. For long term storage of the reconstituted solution it is recommended to add a carrier protein (0.1% HSA or BSA). |
| Formulation | PBS pH 7.2, sterile filtered through 0.2 µm filter. |
Size and pricing
| Pack size | List price (EUR) |
|---|---|
| 10 µg | €50 |
| 5 × 10 µg | €85 |
| 50 µg | €80 |
| 10 × 10 µg | €150 |
| 100 µg | €125 |
| 5 × 100 µg | €525 |
| 10 × 100 µg | €875 |
| 1000 µg | €825 |
| 20 × 100 µg | €1600 |
| 2 × 1000 µg | €1550 |
| 2000 µg | €1500 |
| 50 × 100 µg | €3600 |
| 5 × 1000 µg | €3550 |
| 5000 µg | €3500 |
| Bulk (> 5 mg) | Please inquire |